Lipid-based nanosystems for atherosclerosis treatment: Evolving approaches and novel therapeutic strategies

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Acta Pharmaceutica Sinica B

• Publication date

  2025-11-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/j.apsb.2025.11.001
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Combining Colchicine and Antiplatelet Therapy to Tackle Atherothrombosis: A Paradigm in Transition?

  2025cited by this paper
• Hypertension in atherosclerotic cardiovascular disease: insights into epidemiology, management strategies, and outcomes

  2025cited by this paper
• Rational design and modular synthesis of biodegradable ionizable lipids via the Passerini reaction for mRNA delivery

  2025cited by this paper
• Modular Design of Lipopeptide‐Based Organ‐Specific Targeting (POST) Lipid Nanoparticles for Highly Efficient RNA Delivery

  2025cited by this paper
• Deformable hyaluronic acid niosomes overcome multi-barriers for improved ergothioneine transdermal delivery against UV-induced skin damage

  2025cited by this paper
• Macrophage membrane enveloped on double-locked nanoplatform with right-side-out orientation to improving precise theranostic for atherosclerosis.

  2025cited by this paper
• Engineered bacteria potentiate cancer immunotherapy

  2025cited by this paper
• The 60-year evolution of lipid nanoparticles for nucleic acid delivery

  2024cited by this paper
• Nanoparticles as Drug Delivery Systems for the Targeted Treatment of Atherosclerosis

  2024cited by this paper
• ROS-scavenging lipid-based liquid crystalline as a favorable stem cell extracellular vesicles delivery vector to promote wound healing.

  2024cited by this paper
• Circulating monocyte differentiation-activated nanoprodrugs for reprogramming macrophage immunity in atherosclerotic plaques

  2024cited by this paper
• Acoustic Delivery of Plasma Low-Density Lipoprotein into Liver via ApoB100-Targeted Microbubbles Inhibits Atherosclerotic Plaque Growth.

  2024cited by this paper
• A Macrophage Membrane‐Functionalized, Reactive Oxygen Species‐Activatable Nanoprodrug to Alleviate Inflammation and Improve the Lipid Metabolism for Atherosclerosis Management

  2024cited by this paper
• Targeting immune cell recruitment in atherosclerosis

  2024cited by this paper
• Targeted delivery of MerTK protein via cell membrane engineered nanoparticle enhances efferocytosis and attenuates atherosclerosis in diabetic ApoE−/− Mice

  2024cited by this paper
• Sphingomyelinase-responsive nanomicelles for targeting atherosclerosis.

  2024cited by this paper
• Safety and possible anti-inflammatory effect of paclitaxel associated with LDL-like nanoparticles (LDE) in patients with chronic coronary artery disease: a double-blind, placebo-controlled pilot study

  2024cited by this paper
• Engineered M2 macrophage-derived extracellular vesicles with platelet membrane fusion for targeted therapy of atherosclerosis

  2024cited by this paper
• Biomimetic nanodrug targets inflammation and suppresses YAP/TAZ to ameliorate atherosclerosis.

  2024cited by this paper
• Regulating protein corona on nanovesicles by glycosylated polyhydroxy polymer modification for efficient drug delivery

  2024cited by this paper
• Extracellular vesicles as tools and targets in therapy for diseases

  2024cited by this paper
• A natural nano-platform: Advances in drug delivery system with recombinant high-density lipoprotein

  2024cited by this paper
• Inflammation in atherosclerosis: pathophysiology and mechanisms

  2024cited by this paper
• ROS-responsive biomimetic nanovesicles to plaque microenvironment in targeted therapy of atherosclerosis

  2024cited by this paper
• Targeting Gut Microbiota with Probiotics and Phenolic Compounds in the Treatment of Atherosclerosis: A Comprehensive Review

  2024cited by this paper
• Dual‐Function Nanoscale Coordination Polymer Nanoparticles for Targeted Diagnosis and Therapeutic Delivery in Atherosclerosis

  2024cited by this paper
• Advancements and Challenges of Nanostructured Lipid Carriers for Wound Healing Applications

  2024cited by this paper
• Lipid-based nanosystems: the next generation of cancer immune therapy

  2024cited by this paper
• Exosomes and their engineering strategies, delivery systems, and biomedical applications.

  2023cited by this paper
• Non-clinical evaluation of YN001-a promising drug for atherosclerotic therapy by targeted delivery system

  2023cited by this paper
• An Elastase-inhibiting, Plaque-targeting and Neutrophil-hitchhiking Liposome Against Atherosclerosis.

  2023cited by this paper
• Modulating Plaque Inflammation via Targeted mRNA Nanoparticles for the Treatment of Atherosclerosis.

  2023cited by this paper
• PEG400-mediated nanocarriers improve the delivery and therapeutic efficiency of mRNA tumor vaccines

  2023cited by this paper
• Injectable liposomal docosahexaenoic acid alleviates atherosclerosis progression and enhances plaque stability.

  2023cited by this paper
• Low molecular weight fucoidan modified nanoliposomes for the targeted delivery of the anti-inflammation natural product berberine.

  2023cited by this paper
• Synthetic ditempolphosphatidylcholine liposome-like nanoparticles for anti-oxidative therapy of atherosclerosis

  2023cited by this paper
• Flow-induced reprogramming of endothelial cells in atherosclerosis

  2023cited by this paper
• Fabrication of a Polysaccharide-Protein/Protein Complex Stabilized Oral Nanoemulsion to Facilitate the Therapeutic Effects of 1,8-Cineole on Atherosclerosis.

  2023cited by this paper
• Diagnostics of atherosclerosis: Overview of the existing methods

  2023cited by this paper
• Neutrophil-Membrane-Coated Biomineralized Metal-Organic Framework Nanoparticles for Atherosclerosis Treatment by Targeting Gene Silencing.

  2023cited by this paper
• Lipid-core nanoparticles: Classification, preparation methods, routes of administration and recent advances in cancer treatment.

  2023cited by this paper
• Molecularly targeted nanomedicine enabled by inorganic nanoparticles for atherosclerosis diagnosis and treatment.

  2023cited by this paper
• Non-viral nucleic acid delivery approach: A boon for state-of-the-art gene delivery

  2023cited by this paper
• Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers.

  2022cited by this paper
• Therapeutic potential of exosome‐based personalized delivery platform in chronic inflammatory diseases

  2022cited by this paper
• Recent Advances in Lipid Nanoparticles for Delivery of mRNA

  2022cited by this paper
• Lipid carriers for mRNA delivery

  2022cited by this paper
• Cell-derived nanovesicles from mesenchymal stem cells as extracellular vesicle-mimetics in wound healing

  2022cited by this paper
• Biomimetic Macrophage Membrane and Lipidated Peptide Hybrid Nanovesicles for Atherosclerosis Therapy

  2022cited by this paper
• A nano-enabledbiotinylated anti-LDL theranostic system to modulate systemic LDL cholesterol.

  2022cited by this paper
• Liposomes as biocompatible and smart delivery systems - the current state.

  2022cited by this paper
• Statin therapy for the primary prevention ofatherosclerotic cardiovascular disease: Pros.

  2022cited by this paper
• VCAM-1-binding peptide targeted cationic liposomes containing NLRP3 siRNA to modulate LDL transcytosis as a novel therapy for experimental atherosclerosis.

  2022cited by this paper
• Lipid-Based Nanocarrier Systems for Drug Delivery: Advances and Applications

  2022cited by this paper
• Comparison of DLin-MC3-DMA and ALC-0315 for siRNA Delivery to Hepatocytes and Hepatic Stellate Cells.

  2022cited by this paper
• Targeting Peptide, Fluorescent Reagent Modified Magnetic Liposomes Coated with Rapamycin Target Early Atherosclerotic Plaque and Therapy

  2022cited by this paper
• A Comprehensive Review of PCSK9 Inhibitors

  2022cited by this paper
• Microfluidic Fabrication of Lipid Nanoparticles for the Delivery of Nucleic Acids.

  2022cited by this paper
• Targeting the Microenvironment of Vulnerable Atherosclerotic Plaques: An Emerging Diagnosis and Therapy Strategy for Atherosclerosis

  2022cited by this paper
• Methods of Liposomes Preparation: Formation and Control Factors of Versatile Nanocarriers for Biomedical and Nanomedicine Application

  2022cited by this paper
• Microfluidic technologies and devices for lipid nanoparticle-based RNA delivery

  2022cited by this paper
• Boosting Cholesterol Efflux from Foam Cells by Sequential Administration of rHDL to Deliver MicroRNA and to Remove Cholesterol in a Triple-Cell 2D Atherosclerosis Model.

  2022cited by this paper
• Overexpressed VLA-4 on Endothelial Cell Membrane Camouflaging the Pathological Reactive Oxygen Species Responsive Prodrug to Enhance Target Therapy for Atherosclerosis

  2022cited by this paper
• Biomimetic liposomes hybrid with platelet membranes for targeted therapy of atherosclerosis

  2021cited by this paper
• Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis

  2021cited by this paper
• Cell Membrane-Coated Mimics: A Methodological Approach for Fabrication, Characterization for Therapeutic Applications, and Challenges for Clinical Translation

  2021cited by this paper
• Lipid-based emulsion drug delivery systems — a comprehensive review

  2021cited by this paper
• How the immune system shapes atherosclerosis: roles of innate and adaptive immunity

  2021cited by this paper
• The changing landscape of atherosclerosis

  2021cited by this paper
• Lipid nanoparticles for mRNA delivery

  2021cited by this paper
• LDL delivery of microbial small RNAs drives atherosclerosis through macrophage TLR8

  2021cited by this paper
• "Plug and Play" Functionalized Erythrocyte Nanoplatform for Target Atherosclerosis Management.

  2021cited by this paper
• Lipid Nanoparticles-From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement.

  2021cited by this paper
• The role of extracellular vesicles in regulating local and systemic inflammation in cardiovascular disease.

  2021cited by this paper
• Extracellular Vesicles as Potential Therapeutics for Inflammatory Diseases

  2021cited by this paper
• A Nano-Emulsion Platform Functionalized with a Fully Human scFv-Fc Antibody for Atheroma Targeting: Towards a Theranostic Approach to Atherosclerosis

  2021cited by this paper
• In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates

  2021cited by this paper
• Cell membrane-derived vesicles for delivery of therapeutic agents

  2021cited by this paper
• Atherosclerosis: Conventional intake of cardiovascular drugs versus delivery using nanotechnology - A new chance for causative therapy?

  2021cited by this paper
• Low-density lipoprotein nanomedicines: mechanisms of targeting, biology, and theranostic potential

  2021cited by this paper
• Nanomicelles: Types, properties and applications in drug delivery

  2021cited by this paper
• ROS Responsive Nanoplatform with Two-Photon AIE Imaging for Atherosclerosis Diagnosis and "Two-Pronged" Therapy.

  2020cited by this paper
• Nanostructured lipid carriers accumulate in atherosclerotic plaques of ApoE-/- mice.

  2020cited by this paper
• Shuttle/sink model composed of β-cyclodextrin and simvastatin-loaded discoidal reconstituted high-density lipoprotein for enhanced cholesterol efflux and drug uptake in macrophage/foam cells.

  2020cited by this paper
• SLN and NLC for topical, dermal, and transdermal drug delivery

  2020cited by this paper
• Extracellular vesicles as drug delivery systems: Why and how?

  2020cited by this paper
• Vaccination Strategies and Immune Modulation of Atherosclerosis

  2020cited by this paper
• Treatment of atherosclerosis by macrophage-biomimetic nanoparticles via targeted pharmacotherapy and sequestration of proinflammatory cytokines

  2020cited by this paper
• Developing a vaccine against atherosclerosis

  2020cited by this paper
• Recent advancements in liposome technology.

  2020cited by this paper
• siRNA nanoparticles targeting CaMKIIγ in lesional macrophages improve atherosclerotic plaque stability in mice

  2020cited by this paper
• Lipoprotein-based drug delivery.

  2020cited by this paper
• Endothelial progenitor cell-derived exosomes ameliorate endothelial dysfunction in a mouse model of diabetes.

  2020cited by this paper
• Site‐Specific MicroRNA‐33 Antagonism by pH‐Responsive Nanotherapies for Treatment of Atherosclerosis via Regulating Cholesterol Efflux and Adaptive Immunity

  2020cited by this paper
• Improving protection effects of eucalyptol via carboxymethyl chitosan-coated lipid nanoparticles on hyperglycaemia-induced vascular endothelial injury in rats

  2020cited by this paper
• Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019

  2020cited by this paper
• Chemo-physical Strategies to Advance the in Vivo Functionality of Targeted Nanomedicine: The Next Generation.

  2020cited by this paper
• Cytosolic delivery of nucleic acids: The case of ionizable lipid nanoparticles

  2020cited by this paper
• The apoA-I mimetic peptide 4F protects apolipoprotein A-I from oxidative damage.

  2019cited by this paper
• Lipid-Based Nanocarriers for Lymphatic Transportation

  2019cited by this paper

• No citing papers are available for this paper.